id	sid	eid	entity	type
admet-2861	1	1	1	CARDINAL
admet-2861	1	2	13(5	CARDINAL
admet-2861	1	3	2025	CARDINAL
admet-2861	1	4	2861	CARDINAL
admet-2861	1	5	issn	PERSON
admet-2861	1	6	1848-7718	DATE
admet-2861	1	7	amar elezović1	PERSON
admet-2861	1	8	pilipović1	ORG
admet-2861	1	9	alisa elezović3	PERSON
admet-2861	2	1	1control	CARDINAL
admet-2861	2	2	bosnia	GPE
admet-2861	2	3	herzegovina	GPE
admet-2861	2	4	maršala tita	ORG
admet-2861	2	5	9	CARDINAL
admet-2861	2	6	sarajevo	GPE
admet-2861	2	7	bosnia and	GPE
admet-2861	2	8	beograd	GPE
admet-2861	2	9	serbia	GPE
admet-2861	2	10	zmaja od bosne 8	ORG
admet-2861	2	11	sarajevo	GPE
admet-2861	2	12	bosnia	GPE
admet-2861	3	1	981	CARDINAL
admet-2861	3	2	june 7, 2025	DATE
admet-2861	3	3	august 25, 2025	DATE
admet-2861	3	4	september 4, 2025	DATE
admet-2861	7	1	seven	CARDINAL
admet-2861	13	1	2025	CARDINAL
admet-2861	18	1	http://dx.doi.org/10.5599/admet.2861 https://doi.org/10.5599/admet.2861	PERSON
admet-2861	19	1	a. elezović et al	PERSON
admet-2861	19	2	13(5	CARDINAL
admet-2861	19	3	2025	CARDINAL
admet-2861	19	4	2861 2	CARDINAL
admet-2861	20	1	the european medicines	ORG
admet-2861	20	2	ema	ORG
admet-2861	21	1	1	CARDINAL
admet-2861	22	1	two	CARDINAL
admet-2861	23	1	2	CARDINAL
admet-2861	25	1	udd	ORG
admet-2861	27	1	european	NORP
admet-2861	27	2	2	CARDINAL
admet-2861	28	1	ema	ORG
admet-2861	28	2	1	CARDINAL
admet-2861	29	1	ema	ORG
admet-2861	29	2	3	CARDINAL
admet-2861	30	1	fda	ORG
admet-2861	31	1	2008	DATE
admet-2861	31	2	4	CARDINAL
admet-2861	32	1	2024	DATE
admet-2861	33	1	5	CARDINAL
admet-2861	33	2	6	CARDINAL
admet-2861	34	1	one	CARDINAL
admet-2861	34	2	seven	CARDINAL
admet-2861	35	1	7	CARDINAL
admet-2861	40	1	10-13	CARDINAL
admet-2861	41	1	14	CARDINAL
admet-2861	41	2	17	CARDINAL
admet-2861	41	3	2	CARDINAL
admet-2861	41	4	9,20	CARDINAL
admet-2861	41	5	21	CARDINAL
admet-2861	42	1	12,16,20	CARDINAL
admet-2861	43	1	7,24-26	CARDINAL
admet-2861	44	1	27	CARDINAL
admet-2861	45	1	seven	CARDINAL
admet-2861	46	1	european	NORP
admet-2861	47	1	seven	CARDINAL
admet-2861	47	2	3	CARDINAL
admet-2861	47	3	4	CARDINAL
admet-2861	48	1	bosnia	GPE
admet-2861	48	2	germany	GPE
admet-2861	50	1	13	CARDINAL
admet-2861	50	2	2025	CARDINAL
admet-2861	50	3	2861	CARDINAL
admet-2861	50	4	3	CARDINAL
admet-2861	51	1	2.9.18	CARDINAL
admet-2861	51	2	copley scientific limited	ORG
admet-2861	51	3	uk	GPE
admet-2861	52	1	mmad	GPE
admet-2861	52	2	3.10	CARDINAL
admet-2861	52	3	nottingham	GPE
admet-2861	52	4	uk	GPE
admet-2861	53	1	2 ml	QUANTITY
admet-2861	53	2	2 ml	QUANTITY
admet-2861	53	3	37 °	QUANTITY
admet-2861	53	4	fisher scientific inc.	ORG
admet-2861	53	5	16 hours	TIME
admet-2861	54	1	14,000	CARDINAL
admet-2861	54	2	10 minutes	TIME
admet-2861	54	3	0.22	CARDINAL
admet-2861	56	1	andersen cascade impactor	ORG
admet-2861	56	2	erweka gmbh	PERSON
admet-2861	56	3	germany	GPE
admet-2861	56	4	varian vk 7010	ORG
admet-2861	56	5	, varian inc.	ORG
admet-2861	57	1	5	CARDINAL
admet-2861	58	1	1	CARDINAL
admet-2861	59	1	agarose gel	GPE
admet-2861	59	2	2%	PERCENT
admet-2861	59	3	pbs	ORG
admet-2861	59	4	without 1%	PERCENT
admet-2861	60	1	pbs	ORG
admet-2861	60	2	80 °	QUANTITY
admet-2861	61	1	4.5 ml	QUANTITY
admet-2861	64	1	1	CARDINAL
admet-2861	65	1	27	CARDINAL
admet-2861	65	2	al. admet	ORG
admet-2861	65	3	13(5	CARDINAL
admet-2861	65	4	2025	CARDINAL
admet-2861	65	5	2861 4	DATE
admet-2861	66	1	0	CARDINAL
admet-2861	66	2	1	DATE
admet-2861	66	3	2	DATE
admet-2861	66	4	7	DATE
admet-2861	66	5	4.7 to 0.2 µm	PERCENT
admet-2861	67	1	second	ORDINAL
admet-2861	68	1	1	CARDINAL
admet-2861	68	2	93 mm	QUANTITY
admet-2861	69	1	23 mm	QUANTITY
admet-2861	70	1	300 ml	QUANTITY
admet-2861	70	2	37.5 °	QUANTITY
admet-2861	70	3	pbs	ORG
admet-2861	70	4	1%	PERCENT
admet-2861	71	1	100	CARDINAL
admet-2861	72	1	25 mm	QUANTITY
admet-2861	72	2	5 mm	QUANTITY
admet-2861	73	1	1 ml	QUANTITY
admet-2861	74	1	first	ORDINAL
admet-2861	74	2	higuchi	GPE
admet-2861	74	3	hixon-crowell	ORG
admet-2861	76	1	microsoft	ORG
admet-2861	77	1	9.8	CARDINAL
admet-2861	77	2	lancaster, usa	ORG
admet-2861	78	1	two	CARDINAL
admet-2861	78	2	bdp	ORG
admet-2861	79	1	bdp	ORG
admet-2861	79	2	17-monopropionate	QUANTITY
admet-2861	79	3	30	CARDINAL
admet-2861	80	1	gastroplus®	PRODUCT
admet-2861	81	1	31	CARDINAL
admet-2861	82	1	32,33	CARDINAL
admet-2861	83	1	1	CARDINAL
admet-2861	84	1	sx	ORG
admet-2861	84	2	2	CARDINAL
admet-2861	84	3	3	CARDINAL
admet-2861	85	1	two	CARDINAL
admet-2861	86	1	mmad	GPE
admet-2861	86	2	1	CARDINAL
admet-2861	86	3	0.880 µm	MONEY
admet-2861	86	4	1.028	CARDINAL
admet-2861	86	5	1.683	CARDINAL
admet-2861	87	1	2	CARDINAL
admet-2861	88	1	13	CARDINAL
admet-2861	88	2	2025	CARDINAL
admet-2861	88	3	2861	CARDINAL
admet-2861	88	4	5	CARDINAL
admet-2861	88	5	1	CARDINAL
admet-2861	88	6	2	CARDINAL
admet-2861	88	7	25	CARDINAL
admet-2861	88	8	3.042	CARDINAL
admet-2861	88	9	2.154	CARDINAL
admet-2861	88	10	0.53546	CARDINAL
admet-2861	88	11	25	CARDINAL
admet-2861	88	12	1.865	CARDINAL
admet-2861	88	13	1.648	CARDINAL
admet-2861	88	14	0.68932	CARDINAL
admet-2861	88	15	25	CARDINAL
admet-2861	88	16	3.415	CARDINAL
admet-2861	88	17	1.669	CARDINAL
admet-2861	88	18	0.40170 s4	QUANTITY
admet-2861	88	19	25	CARDINAL
admet-2861	88	20	1.535	CARDINAL
admet-2861	88	21	1.493	CARDINAL
admet-2861	88	22	0.49371	CARDINAL
admet-2861	89	1	100	CARDINAL
admet-2861	89	2	0.880	CARDINAL
admet-2861	89	3	1.721	CARDINAL
admet-2861	89	4	100	CARDINAL
admet-2861	89	5	norflurane ethanol formoterol	ORG
admet-2861	89	6	1.028	CARDINAL
admet-2861	89	7	1.881	CARDINAL
admet-2861	89	8	0.57701	CARDINAL
admet-2861	89	9	250	CARDINAL
admet-2861	89	10	1.683	CARDINAL
admet-2861	89	11	2.097	CARDINAL
admet-2861	89	12	0.56342	CARDINAL
admet-2861	89	13	2	CARDINAL
admet-2861	89	14	3	CARDINAL
admet-2861	90	1	mmad	GPE
admet-2861	90	2	1	CARDINAL
admet-2861	92	1	al. admet	ORG
admet-2861	92	2	13(5	CARDINAL
admet-2861	92	3	2025	CARDINAL
admet-2861	92	4	2861 6	DATE
admet-2861	92	5	four	CARDINAL
admet-2861	93	1	four	CARDINAL
admet-2861	93	2	25	CARDINAL
admet-2861	95	1	ema	ORG
admet-2861	95	2	34	CARDINAL
admet-2861	97	1	9-11,14	CARDINAL
admet-2861	97	2	15,17-21,23	CARDINAL
admet-2861	97	3	two	CARDINAL
admet-2861	106	1	35	CARDINAL
admet-2861	107	1	aci	PERSON
admet-2861	108	1	2	CARDINAL
admet-2861	108	2	4.7	CARDINAL
admet-2861	108	3	7	CARDINAL
admet-2861	108	4	0.7 µm	MONEY
admet-2861	109	1	aci	PERSON
admet-2861	109	2	0	CARDINAL
admet-2861	109	3	1	DATE
admet-2861	109	4	2	DATE
admet-2861	109	5	7	DATE
admet-2861	110	1	4.7	CARDINAL
admet-2861	110	2	7	CARDINAL
admet-2861	115	1	one	CARDINAL
admet-2861	120	1	less than 5	CARDINAL
admet-2861	120	2	13	CARDINAL
admet-2861	120	3	2025	CARDINAL
admet-2861	120	4	2861	CARDINAL
admet-2861	122	1	aci	PERSON
admet-2861	122	2	2	CARDINAL
admet-2861	123	1	2	CARDINAL
admet-2861	125	1	2	CARDINAL
admet-2861	125	2	2	CARDINAL
admet-2861	125	3	27.126	CARDINAL
admet-2861	125	4	21.809	CARDINAL
admet-2861	125	5	9.131	CARDINAL
admet-2861	125	6	5.563	CARDINAL
admet-2861	125	7	9.593	CARDINAL
admet-2861	127	1	first	ORDINAL
admet-2861	129	1	36	CARDINAL
admet-2861	131	1	5 to 100	CARDINAL
admet-2861	131	2	0.1-0.2 µm	PERCENT
admet-2861	131	3	37	CARDINAL
admet-2861	132	1	39	CARDINAL
admet-2861	133	1	pbs	ORG
admet-2861	133	2	7.4	CARDINAL
admet-2861	134	1	pbs	ORG
admet-2861	136	1	at least three	CARDINAL
admet-2861	136	2	40	CARDINAL
admet-2861	138	1	80	CARDINAL
admet-2861	139	1	pbs	ORG
admet-2861	139	2	0.155 mg	QUANTITY
admet-2861	140	1	pbs	ORG
admet-2861	140	2	bdp	ORG
admet-2861	140	3	pbs	ORG
admet-2861	140	4	2.1 µg ml-1	QUANTITY
admet-2861	141	1	41	CARDINAL
admet-2861	143	1	80	CARDINAL
admet-2861	143	2	pbs	ORG
admet-2861	144	1	3	CARDINAL
admet-2861	145	1	bdp	ORG
admet-2861	145	2	0.5	CARDINAL
admet-2861	145	3	1 %	PERCENT
admet-2861	145	4	three	CARDINAL
admet-2861	145	5	10 µg ml-1	QUANTITY
admet-2861	146	1	1 %	PERCENT
admet-2861	146	2	bdp	ORG
admet-2861	147	1	https://doi.org/10.5599/admet.2861 a. elezović et al	PERSON
admet-2861	147	2	13(5	CARDINAL
admet-2861	147	3	2025	CARDINAL
admet-2861	147	4	2861 8	DATE
admet-2861	147	5	3	CARDINAL
admet-2861	147	6	pbs	ORG
admet-2861	147	7	2.96 1 %	PERCENT
admet-2861	147	8	80	CARDINAL
admet-2861	147	9	pbs	ORG
admet-2861	147	10	9.64 0.5 %	PERCENT
admet-2861	147	11	pbs	ORG
admet-2861	147	12	48.96 1 %	PERCENT
admet-2861	147	13	pbs	ORG
admet-2861	147	14	93.16	CARDINAL
admet-2861	148	1	9,14-21,24,42,43	CARDINAL
admet-2861	152	1	97 %	PERCENT
admet-2861	152	2	3 %	PERCENT
admet-2861	153	1	44	CARDINAL
admet-2861	159	1	5	CARDINAL
admet-2861	161	1	aci	ORG
admet-2861	168	1	half	CARDINAL
admet-2861	172	1	300 ml	QUANTITY
admet-2861	173	1	1	CARDINAL
admet-2861	173	2	25 mm	QUANTITY
admet-2861	173	3	5 mm	QUANTITY
admet-2861	174	1	13	CARDINAL
admet-2861	174	2	2025	CARDINAL
admet-2861	174	3	2861	CARDINAL
admet-2861	177	1	the united states pharmacopoeia	GPE
admet-2861	177	2	50	CARDINAL
admet-2861	177	3	75	DATE
admet-2861	177	4	100	CARDINAL
admet-2861	178	1	bdp	ORG
admet-2861	178	2	50	CARDINAL
admet-2861	179	1	50	CARDINAL
admet-2861	179	2	the first hour	TIME
admet-2861	180	1	100	CARDINAL
admet-2861	180	2	4	CARDINAL
admet-2861	181	1	100	CARDINAL
admet-2861	182	1	100	CARDINAL
admet-2861	183	1	100	CARDINAL
admet-2861	187	1	4	CARDINAL
admet-2861	187	2	b3	GPE
admet-2861	187	3	1	CARDINAL
admet-2861	187	4	2	CARDINAL
admet-2861	187	5	two	CARDINAL
admet-2861	190	1	10	CARDINAL
admet-2861	191	1	https://doi.org/10.5599/admet.2861 a. elezović et al	PERSON
admet-2861	191	2	13(5	CARDINAL
admet-2861	191	3	2025	CARDINAL
admet-2861	191	4	2861 10	DATE
admet-2861	192	1	5	CARDINAL
admet-2861	192	2	5	CARDINAL
admet-2861	193	1	5	CARDINAL
admet-2861	194	1	5	CARDINAL
admet-2861	194	2	10	CARDINAL
admet-2861	195	1	11.6	CARDINAL
admet-2861	195	2	53.8	CARDINAL
admet-2861	196	1	bdp	ORG
admet-2861	197	1	bdp	ORG
admet-2861	198	1	first	ORDINAL
admet-2861	199	1	10	CARDINAL
admet-2861	199	2	15	CARDINAL
admet-2861	200	1	6	CARDINAL
admet-2861	201	1	7.5	CARDINAL
admet-2861	201	2	78.0	CARDINAL
admet-2861	203	1	6	CARDINAL
admet-2861	204	1	10 and 15	CARDINAL
admet-2861	204	2	13	CARDINAL
admet-2861	204	3	2025	CARDINAL
admet-2861	204	4	2861	CARDINAL
admet-2861	204	5	7	CARDINAL
admet-2861	205	1	121.56	CARDINAL
admet-2861	205	2	78.06	CARDINAL
admet-2861	205	3	aci	ORG
admet-2861	206	1	one	CARDINAL
admet-2861	212	1	7	CARDINAL
admet-2861	212	2	sx	ORG
admet-2861	212	3	bdp	ORG
admet-2861	213	1	7	CARDINAL
admet-2861	213	2	sx	ORG
admet-2861	213	3	bdp	ORG
admet-2861	214	1	15 %	PERCENT
admet-2861	214	2	bdp	ORG
admet-2861	216	1	two	CARDINAL
admet-2861	216	2	agarose	GPE
admet-2861	217	1	agaropectin	PERSON
admet-2861	217	2	3,6	CARDINAL
admet-2861	217	3	45	CARDINAL
admet-2861	219	1	8	CARDINAL
admet-2861	221	1	4	CARDINAL
admet-2861	223	1	https://doi.org/10.5599/admet.2861 a. elezović et al	PERSON
admet-2861	223	2	13(5	CARDINAL
admet-2861	223	3	2025	CARDINAL
admet-2861	223	4	2861 12	DATE
admet-2861	223	5	8	CARDINAL
admet-2861	224	1	±	CARDINAL
admet-2861	225	1	46	CARDINAL
admet-2861	225	2	47	CARDINAL
admet-2861	226	1	4	CARDINAL
admet-2861	226	2	13.8 52.9	CARDINAL
admet-2861	226	3	25.1 41.8	CARDINAL
admet-2861	226	4	13.3 51.9	QUANTITY
admet-2861	226	5	21.1 42.1	CARDINAL
admet-2861	226	6	5	CARDINAL
admet-2861	226	7	5	CARDINAL
admet-2861	226	8	11.3 57.5	CARDINAL
admet-2861	226	9	10.2	CARDINAL
admet-2861	226	10	11.8 56.2	CARDINAL
admet-2861	226	11	13.4 s1/	QUANTITY
admet-2861	226	12	3.5	CARDINAL
admet-2861	226	13	79.8	CARDINAL
admet-2861	226	14	3.6 s1	QUANTITY
admet-2861	226	15	9.3 62.2	QUANTITY
admet-2861	226	16	5.6 73.2 s4	QUANTITY
admet-2861	226	17	5.9	CARDINAL
admet-2861	226	18	8.1 64.0	QUANTITY
admet-2861	226	19	7.6	CARDINAL
admet-2861	228	1	fluticasone admet &	ORG
admet-2861	228	2	13	CARDINAL
admet-2861	228	3	2025	CARDINAL
admet-2861	228	4	2861	CARDINAL
admet-2861	228	5	13	CARDINAL
admet-2861	229	1	theophilus et al	PERSON
admet-2861	230	1	48	CARDINAL
admet-2861	230	2	mdi	ORG
admet-2861	232	1	1	CARDINAL
admet-2861	235	1	49,50	CARDINAL
admet-2861	236	1	51	CARDINAL
admet-2861	238	1	49,50	CARDINAL
admet-2861	239	1	sx	ORG
admet-2861	240	1	4 and 5	CARDINAL
admet-2861	241	1	sx	ORG
admet-2861	241	2	6	CARDINAL
admet-2861	242	1	6	CARDINAL
admet-2861	243	1	zero	CARDINAL
admet-2861	243	2	first	ORDINAL
admet-2861	243	3	hixson-crowell higuchi r2 s1	ORG
admet-2861	243	4	0.7373 0.8714 0.8305	MONEY
admet-2861	245	1	sx	ORG
admet-2861	246	1	eriksson et al	PERSON
admet-2861	247	1	52	CARDINAL
admet-2861	248	1	9	CARDINAL
admet-2861	249	1	4	CARDINAL
admet-2861	250	1	less than 4 hours	TIME
admet-2861	250	2	53	CARDINAL
admet-2861	250	3	17-monopropionate	QUANTITY
admet-2861	250	4	less than 4 hours	TIME
admet-2861	251	1	30,33	CARDINAL
admet-2861	252	1	https://doi.org/10.5599/admet.2861 a. elezović et	PERSON
admet-2861	252	2	al. admet	ORG
admet-2861	252	3	13(5	CARDINAL
admet-2861	252	4	2025	CARDINAL
admet-2861	252	5	2861 14	DATE
admet-2861	252	6	9	CARDINAL
admet-2861	253	1	bdp	ORG
admet-2861	253	2	±	CARDINAL
admet-2861	254	1	14,54	CARDINAL
admet-2861	256	1	bdp	ORG
admet-2861	256	2	first	ORDINAL
admet-2861	256	3	7	CARDINAL
admet-2861	257	1	7	CARDINAL
admet-2861	258	1	zero	CARDINAL
admet-2861	258	2	first	ORDINAL
admet-2861	258	3	hixson-crowell higuchi r2	ORG
admet-2861	259	1	0.9656	CARDINAL
admet-2861	259	2	0.9110	ORG
admet-2861	259	3	0.9750	CARDINAL
admet-2861	259	4	0.9847	MONEY
admet-2861	259	5	bdp	ORG
admet-2861	259	6	bdp	ORG
admet-2861	260	1	bdp	ORG
admet-2861	260	2	f1	PERSON
admet-2861	260	3	f2	ORG
admet-2861	260	4	8)	CARDINAL
admet-2861	260	5	8	CARDINAL
admet-2861	260	6	16.9 61.4	CARDINAL
admet-2861	260	7	20.4	CARDINAL
admet-2861	260	8	32.4 40.7	CARDINAL
admet-2861	260	9	47.9	CARDINAL
admet-2861	260	10	19.2 50.5	CARDINAL
admet-2861	260	11	23.6	CARDINAL
admet-2861	260	12	three	CARDINAL
admet-2861	260	13	15	CARDINAL
admet-2861	260	14	f2	ORG
admet-2861	261	1	bdp	ORG
admet-2861	262	1	13	CARDINAL
admet-2861	262	2	2025	CARDINAL
admet-2861	262	3	2861	CARDINAL
admet-2861	262	4	bdp	ORG
admet-2861	263	1	1	CARDINAL
admet-2861	263	2	1	CARDINAL
admet-2861	264	1	two	CARDINAL
admet-2861	266	1	9	CARDINAL
admet-2861	266	2	p.o.	GPE
admet-2861	266	3	bdp	ORG
admet-2861	266	4	9	CARDINAL
admet-2861	267	1	bdp	ORG
admet-2861	267	2	bmp-17 bdp	ORG
admet-2861	268	1	bmp-17 bdp p.o.	ORG
admet-2861	268	2	521.1	CARDINAL
admet-2861	268	3	41	CARDINAL
admet-2861	268	4	465.0	CARDINAL
admet-2861	269	1	55	CARDINAL
admet-2861	269	2	521.1	CARDINAL
admet-2861	269	3	41	CARDINAL
admet-2861	269	4	1.30	CARDINAL
admet-2861	269	5	56	CARDINAL
admet-2861	269	6	2.46	CARDINAL
admet-2861	270	1	55	CARDINAL
admet-2861	270	2	1.30	CARDINAL
admet-2861	271	1	55	CARDINAL
admet-2861	271	2	pka -3.3	ORG
admet-2861	271	3	13.85	CARDINAL
admet-2861	272	1	41	CARDINAL
admet-2861	272	2	13.85	CARDINAL
admet-2861	273	1	55	CARDINAL
admet-2861	273	2	13.85	CARDINAL
admet-2861	274	1	41	CARDINAL
admet-2861	274	2	56	CARDINAL
admet-2861	274	3	0.04570	CARDINAL
admet-2861	274	4	57	CARDINAL
admet-2861	274	5	0.00030	CARDINAL
admet-2861	274	6	cm2 s10-5	PERSON
admet-2861	275	1	3.725	MONEY
admet-2861	275	2	6.000	CARDINAL
admet-2861	275	3	l h-1 99.84	DATE
admet-2861	276	1	30	CARDINAL
admet-2861	276	2	136.00	CARDINAL
admet-2861	277	1	30	CARDINAL
admet-2861	277	2	120.00	CARDINAL
admet-2861	277	3	41	CARDINAL
admet-2861	277	4	1000 892 3570	QUANTITY
admet-2861	277	5	0.05	CARDINAL
admet-2861	278	1	41	CARDINAL
admet-2861	278	2	0.47	CARDINAL
admet-2861	279	1	30	CARDINAL
admet-2861	279	2	2.42	CARDINAL
admet-2861	280	1	30	CARDINAL
admet-2861	280	2	4.28	CARDINAL
admet-2861	281	1	30	CARDINAL
admet-2861	281	2	1.403	CARDINAL
admet-2861	281	3	1.403	CARDINAL
admet-2861	281	4	k21e/ h-1 1.530	ORG
admet-2861	281	5	1.997	CARDINAL
admet-2861	281	6	1.997	CARDINAL
admet-2861	281	7	1	CARDINAL
admet-2861	281	8	2	CARDINAL
admet-2861	281	9	2	CARDINAL
admet-2861	281	10	1	CARDINAL
admet-2861	283	1	10a	CARDINAL
admet-2861	283	2	10b	DATE
admet-2861	283	3	10c	CARDINAL
admet-2861	283	4	p.o.	GPE
admet-2861	283	5	bdp	ORG
admet-2861	284	1	10	CARDINAL
admet-2861	285	1	0.893	CARDINAL
admet-2861	285	2	bdp	ORG
admet-2861	285	3	10c	CARDINAL
admet-2861	285	4	10	CARDINAL
admet-2861	286	1	p.o.	ORG
admet-2861	286	2	bdp	ORG
admet-2861	289	1	0.893	CARDINAL
admet-2861	290	1	10	CARDINAL
admet-2861	291	1	bdp bdp	ORG
admet-2861	291	2	i.v. application	PERSON
admet-2861	291	3	bdp bdp	ORG
admet-2861	293	1	0.99	CARDINAL
admet-2861	293	2	only one	CARDINAL
admet-2861	294	1	0.44 %	PERCENT
admet-2861	294	2	https://doi.org/10.5599/admet.2861 a. elezović et al	PERSON
admet-2861	294	3	13(5	CARDINAL
admet-2861	294	4	2025	CARDINAL
admet-2861	294	5	2861 16	DATE
admet-2861	294	6	10	CARDINAL
admet-2861	295	1	i.v. application	PERSON
admet-2861	295	2	i.v. administration	ORG
admet-2861	295	3	bdp	ORG
admet-2861	295	4	three	CARDINAL
admet-2861	298	1	copley scientific	ORG
admet-2861	298	2	nottingham	ORG
admet-2861	298	3	uk	GPE
admet-2861	298	4	2	CARDINAL
admet-2861	299	1	13	CARDINAL
admet-2861	299	2	2025	CARDINAL
admet-2861	299	3	2861	CARDINAL
admet-2861	299	4	mmad and gsd	ORG
admet-2861	300	1	31	CARDINAL
admet-2861	301	1	11	CARDINAL
admet-2861	302	1	11	CARDINAL
admet-2861	303	1	bdp	ORG
admet-2861	303	2	o	DATE
admet-2861	304	1	32	CARDINAL
admet-2861	304	2	33	CARDINAL
admet-2861	304	3	three	CARDINAL
admet-2861	305	1	second	ORDINAL
admet-2861	305	2	1 hour	TIME
admet-2861	306	1	first	ORDINAL
admet-2861	306	2	first	ORDINAL
admet-2861	307	1	28	CARDINAL
admet-2861	307	2	bdp	ORG
admet-2861	308	1	33	CARDINAL
admet-2861	310	1	https://doi.org/10.5599/admet.2861 a. elezović et al	PERSON
admet-2861	310	2	13(5	CARDINAL
admet-2861	310	3	2025	CARDINAL
admet-2861	310	4	2861 18	DATE
admet-2861	310	5	0.99	CARDINAL
admet-2861	311	1	bdp	ORG
admet-2861	311	2	10a	DATE
admet-2861	311	3	first	ORDINAL
admet-2861	311	4	2	CARDINAL
admet-2861	312	1	only one	CARDINAL
admet-2861	313	1	first	ORDINAL
admet-2861	313	2	30 minutes	TIME
admet-2861	313	3	the first 4 minutes	TIME
admet-2861	314	1	ppe	ORG
admet-2861	314	2	0.44 %	PERCENT
admet-2861	316	1	bdp	ORG
admet-2861	316	2	9	CARDINAL
admet-2861	318	1	11	CARDINAL
admet-2861	319	1	11	CARDINAL
admet-2861	320	1	44.01	CARDINAL
admet-2861	320	2	37.22	CARDINAL
admet-2861	320	3	k10	ORG
admet-2861	320	4	6.79×10-3 6.18×10-	CARDINAL
admet-2861	320	5	3 2.53×10-3	CARDINAL
admet-2861	321	1	12.00 9.45 6.66	CARDINAL
admet-2861	321	2	0.04 0.04 0.04	QUANTITY
admet-2861	321	3	2.42×104	CARDINAL
admet-2861	321	4	1.77×104	ORDINAL
admet-2861	321	5	11	CARDINAL
admet-2861	321	6	linear	ORG
admet-2861	322	1	12	CARDINAL
admet-2861	322	2	12	CARDINAL
admet-2861	324	1	r2 ka	PERSON
admet-2861	324	2	k10 / h-1 0.9855	ORG
admet-2861	325	1	0.9415	MONEY
admet-2861	326	1	bdp	ORG
admet-2861	327	1	3	CARDINAL
admet-2861	328	1	k10	ORG
admet-2861	328	2	12	CARDINAL
admet-2861	329	1	k10	ORG
admet-2861	333	1	k10	ORG
admet-2861	333	2	bdp	ORG
admet-2861	334	1	13	CARDINAL
admet-2861	334	2	2025	CARDINAL
admet-2861	334	3	2861	CARDINAL
admet-2861	334	4	19	CARDINAL
admet-2861	335	1	58,59	CARDINAL
admet-2861	337	1	i.v. administration	ORG
admet-2861	339	1	60	CARDINAL
admet-2861	340	1	9	CARDINAL
admet-2861	341	1	bdp i.v.	ORG
admet-2861	341	2	17.15 h-1	QUANTITY
admet-2861	342	1	37.22	CARDINAL
admet-2861	342	2	44.01 h-1	QUANTITY
admet-2861	342	3	6.7910-3 to 2.5310	DATE
admet-2861	345	1	bdp	ORG
admet-2861	345	2	61	CARDINAL
admet-2861	346	1	k10	ORG
admet-2861	348	1	two	CARDINAL
admet-2861	350	1	bdp	ORG
admet-2861	359	1	62	CARDINAL
admet-2861	359	2	sx	ORG
admet-2861	359	3	i.	PERSON
admet-2861	360	1	the https://doi.org/10.5599/admet.2861 a. elezović et al. admet & dmpk 13(5	ORG
admet-2861	360	2	2025	CARDINAL
admet-2861	360	3	2861 20	CARDINAL
admet-2861	362	1	bdp	ORG
admet-2861	362	2	62	CARDINAL
admet-2861	364	1	bdp	ORG
admet-2861	364	2	k10	PERSON
admet-2861	365	1	k10	ORG
admet-2861	367	1	first	ORDINAL
admet-2861	369	1	1	CARDINAL
admet-2861	369	2	european	NORP
admet-2861	371	1	european medicines agency	ORG
admet-2861	371	2	london	GPE
admet-2861	371	3	2006	DATE
admet-2861	372	1	28.04.2025	CARDINAL
admet-2861	373	1	2	CARDINAL
admet-2861	373	2	european	NORP
admet-2861	373	3	11	CARDINAL
admet-2861	373	4	council of europe	ORG
admet-2861	373	5	strasbourg	GPE
admet-2861	373	6	2022	CARDINAL
admet-2861	375	1	3	CARDINAL
admet-2861	375	2	european	NORP
admet-2861	377	1	amsterdam	GPE
admet-2861	377	2	2024	DATE
admet-2861	378	1	28.04.2025	CARDINAL
admet-2861	379	1	4	CARDINAL
admet-2861	379	2	a. hickey	PERSON
admet-2861	379	3	n. davies	PERSON
admet-2861	379	4	c. dunbar	GPE
admet-2861	379	5	t. foster	GPE
admet-2861	379	6	b. olsson	PERSON
admet-2861	379	7	m. sakagami	PERSON
admet-2861	379	8	v. shah	PERSON
admet-2861	379	9	m. smurthwaite	PERSON
admet-2861	379	10	j. veranth	PERSON
admet-2861	379	11	k. zaidi	PERSON
admet-2861	381	1	34(4	CARDINAL
admet-2861	381	2	2008	DATE
admet-2861	381	3	1068	CARDINAL
admet-2861	382	1	5	CARDINAL
admet-2861	383	1	formoterol	ORG
admet-2861	383	2	2024	DATE
admet-2861	384	1	28.04.2025	CARDINAL
admet-2861	385	1	6	CARDINAL
admet-2861	386	1	2024	DATE
admet-2861	387	1	028.04.2025	CARDINAL
admet-2861	388	1	7	CARDINAL
admet-2861	388	2	a. nokhodchi	PERSON
admet-2861	388	3	s. chavan	PERSON
admet-2861	388	4	t. ghafourian	ORG
admet-2861	390	1	2023	CARDINAL
admet-2861	390	2	983	CARDINAL
admet-2861	392	1	8	CARDINAL
admet-2861	392	2	r. bastola	PERSON
admet-2861	392	3	s.c.	GPE
admet-2861	392	4	das.	GPE
admet-2861	393	1	14(12	CARDINAL
admet-2861	393	2	2022	CARDINAL
admet-2861	393	3	2667	CARDINAL
admet-2861	395	1	9	CARDINAL
admet-2861	395	2	m. horng	PERSON
admet-2861	395	3	m. copley	PERSON
admet-2861	395	4	j.t. mcconville	GPE
admet-2861	397	1	17	CARDINAL
admet-2861	397	2	2010	DATE
admet-2861	397	3	6	CARDINAL
admet-2861	398	1	10	CARDINAL
admet-2861	398	2	r.k. pannu	PERSON
admet-2861	398	3	i.w. kellaway	PERSON
admet-2861	400	1	104	CARDINAL
admet-2861	400	2	79	CARDINAL
admet-2861	401	1	11	CARDINAL
admet-2861	401	2	salama	GPE
admet-2861	401	3	d. traini	ORG
admet-2861	401	4	chan	ORG
admet-2861	401	5	a. sung	PERSON
admet-2861	401	6	a.j. ammit	PERSON
admet-2861	403	1	98	CARDINAL
admet-2861	403	2	2009	DATE
admet-2861	403	3	2709	CARDINAL
admet-2861	404	1	13	CARDINAL
admet-2861	404	2	2025	CARDINAL
admet-2861	404	3	2861	CARDINAL
admet-2861	405	1	12	CARDINAL
admet-2861	405	2	f. sonvico	PERSON
admet-2861	405	3	g. varacca	PERSON
admet-2861	405	4	e. quarta	PERSON
admet-2861	405	5	d. d'angelo	PERSON
admet-2861	405	6	b. forbes	PERSON
admet-2861	405	7	f. buttini	PERSON
admet-2861	407	1	2021	CARDINAL
admet-2861	410	1	13	CARDINAL
admet-2861	410	2	f. guareschi	PERSON
admet-2861	410	3	d. d’angelo	PERSON
admet-2861	410	4	s. baldini	PERSON
admet-2861	410	5	s. meto	PERSON
admet-2861	410	6	d. mostafa kamal	PERSON
admet-2861	410	7	f. buttini	PERSON
admet-2861	410	8	r. mösges	GPE
admet-2861	410	9	f. sonvico	PERSON
admet-2861	412	1	16	CARDINAL
admet-2861	412	2	2024	CARDINAL
admet-2861	412	3	989	CARDINAL
admet-2861	413	1	14	CARDINAL
admet-2861	413	2	m. rohrschneider	PERSON
admet-2861	413	3	s. bhagwat	PERSON
admet-2861	413	4	r. krampe	PERSON
admet-2861	413	5	j. breitkreutz	PERSON
admet-2861	413	6	g. hochhaus	PERSON
admet-2861	415	1	12	CARDINAL
admet-2861	415	2	2015	CARDINAL
admet-2861	415	3	2618-2624	CARDINAL
admet-2861	417	1	15	CARDINAL
admet-2861	417	2	d. arora	PERSON
admet-2861	417	3	k.a. shah	PERSON
admet-2861	417	4	m.s.	GPE
admet-2861	417	5	halquist	ORG
admet-2861	417	6	m. sakagami	PERSON
admet-2861	419	1	27	CARDINAL
admet-2861	419	2	2010	DATE
admet-2861	419	3	786	CARDINAL
admet-2861	420	1	https://doi.org/10.1007/s11095-010-0070-5	ORG
admet-2861	421	1	16	CARDINAL
admet-2861	421	2	f. franek	PERSON
admet-2861	421	3	r. fransson	PERSON
admet-2861	421	4	p. bäckman	PERSON
admet-2861	421	5	p.u. andersson	PERSON
admet-2861	422	1	two	CARDINAL
admet-2861	423	1	15	CARDINAL
admet-2861	423	2	5319-5326	DATE
admet-2861	425	1	17	CARDINAL
admet-2861	425	2	m.r.	GPE
admet-2861	427	1	international journal of pharmaceutics 255	ORG
admet-2861	427	2	2003	DATE
admet-2861	427	3	175	CARDINAL
admet-2861	429	1	18	CARDINAL
admet-2861	429	2	n. patel	PERSON
admet-2861	429	3	n. ditchburn	PERSON
admet-2861	429	4	m.j. tobyn	PERSON
admet-2861	431	1	i. drug development	ORG
admet-2861	431	2	26	CARDINAL
admet-2861	431	3	1191-1198	DATE
admet-2861	433	1	19	CARDINAL
admet-2861	433	2	j.t. mcconville	PERSON
admet-2861	435	1	international journal of pharmaceutics	ORG
admet-2861	435	2	382	CARDINAL
admet-2861	435	3	2009	DATE
admet-2861	435	4	15	CARDINAL
admet-2861	437	1	20	CARDINAL
admet-2861	438	1	b. jensen	PERSON
admet-2861	438	2	m. wolkenhauer	PERSON
admet-2861	438	3	m. schneider	PERSON
admet-2861	438	4	c.m. lehr.	ORG
admet-2861	440	1	29	CARDINAL
admet-2861	440	2	2012	DATE
admet-2861	440	3	2157	CARDINAL
admet-2861	442	1	21	CARDINAL
admet-2861	442	2	m. malmlöf	PERSON
admet-2861	442	3	l. havsborn	PERSON
admet-2861	443	1	sjöberg	PERSON
admet-2861	443	2	p. ewing	PERSON
admet-2861	443	3	s. eirefelt	PERSON
admet-2861	443	4	k. ekelund	PERSON
admet-2861	444	1	dissolvit	PERSON
admet-2861	445	1	15 (2017	PERCENT
admet-2861	445	2	77-88	DATE
admet-2861	447	1	22	CARDINAL
admet-2861	448	1	disolvit	PERSON
admet-2861	448	2	https://www.inhalation.se/inhalation-researchservices/dissolvit-in-vitro-dissolution/	ORG
admet-2861	449	1	12.06.2022.	DATE
admet-2861	450	1	23	CARDINAL
admet-2861	450	2	m. malmlöf	PERSON
admet-2861	450	3	e. selg	PERSON
admet-2861	452	1	journal of aerosol	ORG
admet-2861	452	2	151	CARDINAL
admet-2861	452	3	2021	CARDINAL
admet-2861	453	1	24	CARDINAL
admet-2861	453	2	j. djuris	PERSON
admet-2861	453	3	s. cvijic	PERSON
admet-2861	453	4	s. rozou	PERSON
admet-2861	453	5	p. russo	PERSON
admet-2861	453	6	g. colombo	PERSON
admet-2861	453	7	a. rossi	PERSON
admet-2861	455	1	european journal of pharmaceutical sciences	ORG
admet-2861	455	2	113	CARDINAL
admet-2861	455	3	2018	DATE
admet-2861	455	4	18	CARDINAL
admet-2861	457	1	25	CARDINAL
admet-2861	457	2	c. ehrhardt	PERSON
admet-2861	459	1	istanbul journal of pharmacy 53 (	ORG
admet-2861	459	2	2023	CARDINAL
admet-2861	459	3	239	CARDINAL
admet-2861	460	1	https://doi.org/10.26650/istanbuljpharm.2023.1005069	ORG
admet-2861	460	2	26	CARDINAL
admet-2861	460	3	s. radivojev	PERSON
admet-2861	460	4	s. zellnitz	PERSON
admet-2861	460	5	a. paudel	PERSON
admet-2861	460	6	e. fröhlich	PERSON
admet-2861	462	1	international journal of pharmaceutics	ORG
admet-2861	462	2	556	CARDINAL
admet-2861	462	3	4556	DATE
admet-2861	464	1	27	CARDINAL
admet-2861	464	2	s. cvijić	PERSON
admet-2861	464	3	a. elezović	PERSON
admet-2861	464	4	s. pilipović, a. uzunović	PERSON
admet-2861	464	5	j. parojčić	PERSON
admet-2861	466	1	b. noszal	PERSON
admet-2861	466	2	ed	PERSON
admet-2861	467	1	european	NORP
admet-2861	471	1	a. elezović et al	PERSON
admet-2861	471	2	13(5	CARDINAL
admet-2861	471	3	2025	CARDINAL
admet-2861	471	4	2861 22	DATE
admet-2861	471	5	szeged	ORG
admet-2861	471	6	hungary	GPE
admet-2861	471	7	2018	DATE
admet-2861	472	1	134	CARDINAL
admet-2861	472	2	135	CARDINAL
admet-2861	473	1	28	CARDINAL
admet-2861	473	2	m.n. sahib	GPE
admet-2861	473	3	y. darwis	PERSON
admet-2861	473	4	p.k. khiang	GPE
admet-2861	473	5	fung tan	PERSON
admet-2861	474	1	beclate-50	DATE
admet-2861	474	2	34 (2011	DATE
admet-2861	474	3	613	CARDINAL
admet-2861	476	1	29	CARDINAL
admet-2861	476	2	e. paczkowska	PERSON
admet-2861	476	3	d. smukowska	PERSON
admet-2861	476	4	e. tratkiewicz	PERSON
admet-2861	478	1	27	CARDINAL
admet-2861	479	1	309	CARDINAL
admet-2861	481	1	30	CARDINAL
admet-2861	481	2	p.t	ORG
admet-2861	481	3	daley-yates	PERSON
admet-2861	481	4	a.c.	GPE
admet-2861	481	5	j.r. sisson	PERSON
admet-2861	481	6	a. pereira	PERSON
admet-2861	481	7	n. dallow	PERSON
admet-2861	483	1	british	NORP
admet-2861	483	2	51	CARDINAL
admet-2861	483	3	2001	DATE
admet-2861	483	4	400	CARDINAL
admet-2861	485	1	31	CARDINAL
admet-2861	485	2	a. elezović	PERSON
admet-2861	485	3	s. cvijić	PERSON
admet-2861	485	4	a. elezović	PERSON
admet-2861	485	5	s. pilipović	PERSON
admet-2861	485	6	j. parojčić	PERSON
admet-2861	486	1	a. badnjevic	PERSON
admet-2861	486	2	l. gurbeta pokvić	PERSON
admet-2861	486	3	2021	DATE
admet-2861	487	1	2021	CARDINAL
admet-2861	488	1	84	CARDINAL
admet-2861	491	1	638-644	CARDINAL
admet-2861	492	1	32	CARDINAL
admet-2861	492	2	l.i. harrison	PERSON
admet-2861	492	3	s. kurup	PERSON
admet-2861	492	4	c. wagner	PERSON
admet-2861	492	5	b.p	PERSON
admet-2861	492	6	ekholm	GPE
admet-2861	492	7	j.s. larson	PERSON
admet-2861	492	8	h.b. kaiser	ORG
admet-2861	493	1	17-monopropionate	QUANTITY
admet-2861	494	1	european journal	ORG
admet-2861	494	2	58	DATE
admet-2861	494	3	2002	DATE
admet-2861	494	4	197	CARDINAL
admet-2861	495	1	33	CARDINAL
admet-2861	495	2	d. singh	GPE
admet-2861	495	3	a. piccinno	PERSON
admet-2861	495	4	z. borrill	PERSON
admet-2861	495	5	g. poli	PERSON
admet-2861	495	6	d. acerbi	PERSON
admet-2861	495	7	l. meuleners	PERSON
admet-2861	495	8	a. woodcock	PERSON
admet-2861	496	1	the hfa modulite beclomethasone dipropionate/formoterol combination	PRODUCT
admet-2861	497	1	21 (2008	DATE
admet-2861	497	2	551	CARDINAL
admet-2861	499	1	34	CARDINAL
admet-2861	499	2	european	NORP
admet-2861	500	1	two	CARDINAL
admet-2861	501	1	european	NORP
admet-2861	502	1	london	GPE
admet-2861	502	2	uk	GPE
admet-2861	502	3	2009	DATE
admet-2861	503	1	28.04.2025	CARDINAL
admet-2861	504	1	35	CARDINAL
admet-2861	504	2	g. ljungkvist	PERSON
admet-2861	504	3	e. ljungström	PERSON
admet-2861	504	4	a.c. olin	PERSON
admet-2861	505	1	20	CARDINAL
admet-2861	506	1	36	CARDINAL
admet-2861	506	2	h. bachofen	PERSON
admet-2861	506	3	s. schürch	PERSON
admet-2861	508	1	129(1	CARDINAL
admet-2861	508	2	2001	DATE
admet-2861	508	3	183	CARDINAL
admet-2861	510	1	37	CARDINAL
admet-2861	510	2	a. bidani	PERSON
admet-2861	510	3	t.a.	PERSON
admet-2861	510	4	2004	DATE
admet-2861	510	5	297	CARDINAL
admet-2861	511	1	38	CARDINAL
admet-2861	511	2	s. orgeig	PERSON
admet-2861	513	1	18 (2003	DATE
admet-2861	513	2	151	CARDINAL
admet-2861	515	1	39	CARDINAL
admet-2861	515	2	e. innes	PERSON
admet-2861	515	3	p. mclean	PERSON
admet-2861	515	4	w. brown	PERSON
admet-2861	515	5	m. boyles	PERSON
admet-2861	517	1	51	CARDINAL
admet-2861	517	2	2021	CARDINAL
admet-2861	517	3	217	CARDINAL
admet-2861	519	1	40	CARDINAL
admet-2861	519	2	d.j. phillips	ORG
admet-2861	519	3	s.r.	GPE
admet-2861	519	4	v.b. cooper	PERSON
admet-2861	519	5	j.c. mann	PERSON
admet-2861	521	1	64	CARDINAL
admet-2861	521	2	2012	DATE
admet-2861	521	3	1549-1559	DATE
admet-2861	523	1	41	CARDINAL
admet-2861	523	2	18.01.2021	CARDINAL
admet-2861	526	1	https://doi.org/10.1111/j.2042-7158.2012.01523.x https://go.drugbank.com/drugs/db00394 admet &	ORG
admet-2861	526	2	13	CARDINAL
admet-2861	526	3	2025	CARDINAL
admet-2861	526	4	2861	CARDINAL
admet-2861	526	5	42	CARDINAL
admet-2861	526	6	t. riley	GPE
admet-2861	526	7	d. christopher	PERSON
admet-2861	526	8	j. arp	PERSON
admet-2861	526	9	a. casazza	PERSON
admet-2861	526	10	a. colombani	PERSON
admet-2861	526	11	a. cooper	PERSON
admet-2861	526	12	m. dey	PERSON
admet-2861	526	13	j. maas	PERSON
admet-2861	526	14	j. mitchell	PERSON
admet-2861	526	15	m. reiners	PERSON
admet-2861	526	16	t. tougas	GPE
admet-2861	526	17	s. lyapustina	PERSON
admet-2861	528	1	13	CARDINAL
admet-2861	528	2	2012	DATE
admet-2861	528	3	978	CARDINAL
admet-2861	529	1	43	CARDINAL
admet-2861	531	1	heng	PERSON
admet-2861	532	1	anderson	PERSON
admet-2861	533	1	international journal of pharmaceutics	ORG
admet-2861	533	2	545	CARDINAL
admet-2861	533	3	2018	DATE
admet-2861	533	4	45	CARDINAL
admet-2861	535	1	44	CARDINAL
admet-2861	535	2	fahy	ORG
admet-2861	535	3	b.f. dickey	ORG
admet-2861	537	1	the new england journal of medicine 363	ORG
admet-2861	537	2	2010	DATE
admet-2861	537	3	2233-2247	CARDINAL
admet-2861	538	1	https://doi.org/10.1056/nejmra0910061	NORP
admet-2861	539	1	45	CARDINAL
admet-2861	539	2	j. varshosaz	PERSON
admet-2861	539	3	m.r. zaki	PERSON
admet-2861	539	4	m. minaiyan	PERSON
admet-2861	539	5	j. banoozadeh	PERSON
admet-2861	540	1	biomed research international 2015 (	ORG
admet-2861	540	2	2015) 571816	DATE
admet-2861	541	1	https://doi.org/10.1155/2015/571816	ORG
admet-2861	542	1	46	CARDINAL
admet-2861	542	2	conti	ORG
admet-2861	542	3	j. grashik	PERSON
admet-2861	542	4	l. yang	PERSON
admet-2861	542	5	l. wu	PERSON
admet-2861	542	6	da rocha	PERSON
admet-2861	543	1	solvation	ORG
admet-2861	544	1	64	CARDINAL
admet-2861	544	2	2012	DATE
admet-2861	544	3	1236	CARDINAL
admet-2861	546	1	47	CARDINAL
admet-2861	546	2	ferguson	PERSON
admet-2861	546	3	a.j. hickey	PERSON
admet-2861	546	4	s. dwivedi	PERSON
admet-2861	548	1	134	CARDINAL
admet-2861	548	2	2018	DATE
admet-2861	548	3	16	CARDINAL
admet-2861	550	1	48	CARDINAL
admet-2861	550	2	a. theophilus	PERSON
admet-2861	550	3	a. moore	PERSON
admet-2861	550	4	d. prime	GPE
admet-2861	550	5	s. rossomanno	PERSON
admet-2861	550	6	b. whitcher	PERSON
admet-2861	550	7	h. chrystyn	PERSON
admet-2861	552	1	international journal of pharmaceutics	ORG
admet-2861	552	2	313	CARDINAL
admet-2861	552	3	2006	DATE
admet-2861	552	4	14	CARDINAL
admet-2861	554	1	49	CARDINAL
admet-2861	554	2	s. kirchberg	PERSON
admet-2861	554	3	g. ziegmann	PERSON
admet-2861	556	1	207	CARDINAL
admet-2861	556	2	2011	DATE
admet-2861	556	3	311	CARDINAL
admet-2861	557	1	50	CARDINAL
admet-2861	557	2	n. yongjian	PERSON
admet-2861	557	3	y. lan	PERSON
admet-2861	557	4	z. shijie	PERSON
admet-2861	557	5	c. xueli	PERSON
admet-2861	558	1	east china university of science	ORG
admet-2861	558	2	47	CARDINAL
admet-2861	558	3	2021	CARDINAL
admet-2861	558	4	408	CARDINAL
admet-2861	559	1	51	CARDINAL
admet-2861	559	2	a.j. schoonen	PERSON
admet-2861	559	3	j.t.	GPE
admet-2861	561	1	pharmaceutical sciences	ORG
admet-2861	561	2	65	CARDINAL
admet-2861	561	3	1976	DATE
admet-2861	561	4	843	CARDINAL
admet-2861	563	1	52	CARDINAL
admet-2861	563	2	j. eriksson	PERSON
admet-2861	563	3	e. sjögren	PERSON
admet-2861	563	4	h. thörn	PERSON
admet-2861	563	5	k. rubin	PERSON
admet-2861	563	6	p. bäckman	PERSON
admet-2861	563	7	h. lennernäs	PERSON
admet-2861	564	1	ten	CARDINAL
admet-2861	565	1	european journal of pharmaceutics	ORG
admet-2861	565	2	biopharmaceutics	ORG
admet-2861	565	3	124	CARDINAL
admet-2861	565	4	2018	DATE
admet-2861	565	5	1	CARDINAL
admet-2861	567	1	53	CARDINAL
admet-2861	567	2	w. möller	PERSON
admet-2861	567	3	k. häussinger	PERSON
admet-2861	567	4	l. ziegler-heitbrock	PERSON
admet-2861	567	5	j. heyder	PERSON
admet-2861	568	1	mucociliary	PERSON
admet-2861	569	1	7 (2006) 10	DATE
admet-2861	571	1	54	CARDINAL
admet-2861	571	2	r. price	PERSON
admet-2861	571	3	j. shur	PERSON
admet-2861	571	4	w. ganley	PERSON
admet-2861	571	5	g. farias	PERSON
admet-2861	571	6	d.s. conti	PERSON
admet-2861	571	7	r. delvadia	PERSON
admet-2861	571	8	m. absar	PERSON
admet-2861	571	9	b. saluja	PERSON
admet-2861	571	10	s. lee.	PERSON
admet-2861	573	1	22	CARDINAL
admet-2861	573	2	2020	DATE
admet-2861	573	3	47	DATE
admet-2861	575	1	55	CARDINAL
admet-2861	575	2	17-monopropionate	QUANTITY
admet-2861	575	3	18.01.2021	CARDINAL
admet-2861	576	1	56	CARDINAL
admet-2861	577	1	18.01.2021	CARDINAL
admet-2861	578	1	57	CARDINAL
admet-2861	580	1	92	CARDINAL
admet-2861	580	2	1998	DATE
admet-2861	580	3	2	CARDINAL
admet-2861	582	1	58	CARDINAL
admet-2861	582	2	yáñez	ORG
admet-2861	582	3	c.m. remsberg	PERSON
admet-2861	583	1	c.l. sayre	PERSON
admet-2861	583	2	m.l. forrest	PERSON
admet-2861	583	3	n.m. davies	PERSON
admet-2861	585	1	2	CARDINAL
admet-2861	585	2	643	CARDINAL
admet-2861	587	1	https://doi.org/10.5599/admet.2861	PERSON
admet-2861	587	2	https://doi.org/10.1056/nejmra0910061	NORP
admet-2861	588	1	https://doi.org/10.1016/j.powtec.2010.11.012 https://link.oversea.cnki.net/doi/10.14135/j.cnki.1006-3080.20200328001	PERSON
admet-2861	589	1	https://doi.org/10.4155/tde.11.19 a. elezović et al. admet	PERSON
admet-2861	589	2	13(5	CARDINAL
admet-2861	589	3	2025	CARDINAL
admet-2861	589	4	2861 24	DATE
admet-2861	590	1	59	CARDINAL
admet-2861	590	2	h. boxenbaum	PERSON
admet-2861	592	1	1	CARDINAL
admet-2861	592	2	1998	DATE
admet-2861	592	3	90-91	CARDINAL
admet-2861	593	1	28.04.2025	CARDINAL
admet-2861	594	1	60	CARDINAL
admet-2861	594	2	davis	ORG
admet-2861	594	3	chapter 2	LAW
admet-2861	594	4	fourth	ORDINAL
admet-2861	594	5	s.m. reed	PERSON
admet-2861	594	6	w.m. bayly	ORG
admet-2861	594	7	d.c.	GPE
admet-2861	594	8	w.b. saunders 2018	ORG
admet-2861	594	9	79	CARDINAL
admet-2861	594	10	137	CARDINAL
admet-2861	594	11	978	CARDINAL
admet-2861	595	1	61	CARDINAL
admet-2861	595	2	g. hochhaus	PERSON
admet-2861	595	3	h. möllmann	PERSON
admet-2861	595	4	h. derendorf	PERSON
admet-2861	595	5	r.j. gonzalez-rothi	PERSON
admet-2861	598	1	37 (1997	DATE
admet-2861	598	2	881	CARDINAL
admet-2861	600	1	62	CARDINAL
admet-2861	600	2	hastedt	PERSON
admet-2861	600	3	p. bäckman	PERSON
admet-2861	600	4	a. cabal	PERSON
admet-2861	600	5	a. clark	PERSON
admet-2861	600	6	c. ehrhardt	GPE
admet-2861	600	7	b. forbes	PERSON
admet-2861	600	8	a.j. hickey	PERSON
admet-2861	600	9	g. hochhaus	PERSON
admet-2861	600	10	w. jiang	PERSON
admet-2861	600	11	s. kassinos	PERSON
admet-2861	600	12	p.j.	GPE
admet-2861	600	13	kuehl	ORG
admet-2861	600	14	d. prime	GPE
admet-2861	600	15	y.j.	GPE
admet-2861	600	16	s. teague	PERSON
admet-2861	600	17	j. wylie	PERSON
admet-2861	601	1	3	CARDINAL
admet-2861	601	2	biopharmaceutics	ORG
admet-2861	602	1	21	DATE
admet-2861	602	2	2024	CARDINAL
admet-2861	602	3	164	CARDINAL
admet-2861	603	1	2025	CARDINAL
admet-2861	603	2	iapc	ORG
admet-2861	603	3	zagreb	GPE
admet-2861	603	4	croatia	GPE
admet-2861	605	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-2861	607	1	http://creativecommons.org/licenses/by/3.0/	ORG